Search

everythinglearnresearchcommunity

for

Search:↓

The silk fibroin hydrogel with FGF-2-liposome can potentially treat hair loss in mice.

Ruxolitinib significantly improves multiple autoimmune conditions in APS-1 patients.

Treatment with a hormone agonist can reduce excess male hormones in postmenopausal women without surgery.

CD2 might be a new treatment target for patchy alopecia areata.

Finasteride and methadone don't increase advanced liver disease risk in HCV+ male veterans.

Self-monitoring blood pressure in pregnant women didn't improve outcomes, diabetes drugs may increase gallbladder disease risk, a new drug helps severe hair loss, a plant-based COVID-19 vaccine is 69.5% effective, and new anticoagulants are safer for diabetics with heart rhythm issues than warfarin.

The new delivery system improved raloxifene's skin absorption and effectiveness against cancer cells.

Ixekizumab has known and some unexpected side effects.

Irish dermatologists use JAK inhibitors for alopecia areata but want standardized treatment guidelines.

CO2 fractional laser treatment helped regrow hair in a 13-year-old with alopecia areata.

Intralesional methotrexate effectively treats patchy alopecia areata by reducing inflammation.

Baricitinib was effective in treating a patient with dermatomyositis and hair loss.

Diphencyprone is effective for treating patchy hair loss in alopecia areata, but tacrolimus is not.

JAK inhibitors may effectively treat lichen planopilaris and frontal fibrosing alopecia with minimal side effects.

Targeting thyroid hormone receptor α in liver cells may help treat liver fibrosis.

Cryotherapy with precise temperature control is a promising treatment for alopecia areata.

Alopecia areata is a hair loss disease caused by complex immune reactions, and new targeted treatments show promise.

PRP injections may be an effective treatment for severe hair loss.

Oral JAK inhibitors are safe for alopecia areata, but baricitinib may cause more acne and infections.

A patient's grey hair regained color during treatment with adalimumab.

Some treatments can help with a hair loss condition called alopecia areata, but none ensure lasting results; choices depend on the person, with JAK inhibitors showing promise for severe cases.

5αR inhibitors help slow early prostate cancer cell growth, suggesting combined treatments are needed.

Lifestyle changes are more effective than medication for reducing type 2 diabetes risk.

Alkaloids help fight influenza in animals but need more research for human use.

Compounds 15, 20, and 25 are strong inhibitors of human steroid 5α-reductase type 2.

AI can help track and improve hair loss treatment outcomes.

Afatinib often causes skin problems that need proactive management.

Increased TEMRA cells can predict treatment outcomes in rapidly progressive alopecia areata.

5-alpha-reductase inhibitors lower PSA density but higher PSA density indicates disease progression.

A man's skin cancer improved and some of his hair grew back after treatment with a special light therapy and a medication.